Warning: Undefined array key "HTTP_ACCEPT_LANGUAGE" in /home/u596154002/domains/usbusinessreviews.com/public_html/wp-includes/load.php on line 2057

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rank-math domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u596154002/domains/usbusinessreviews.com/public_html/wp-includes/functions.php on line 6114
Medicaid plans scrap, revise tools with racial biases, survey shows - Best Business Review Site 2024

Medicaid plans scrap, revise tools with racial biases, survey shows

[ad_1]

A majority of Medicaid managed care organizations have modified or abandoned algorithms, policies or models they determined to be racially biased, according to survey results the Institute for Medicaid Innovation released Friday.

The institute found that 88% of Medicaid carriers revised health management tools to remove biases that negatively affected the health of people of color over the year prior to the survey. Health insurance companies including Kaiser Permanente, Centene and UnitedHealthcare are also collecting more information about their policyholders, including race, ethnicity, language and social determinants of health data.

The efforts go hand in hand. Insurers hope to use the data to address health disparities and to identify when their own algorithms and models may be exacerbating them.

Aetna, CareSource, Elevance Health, Humana, Independence Blue Cross, Kaiser Permanente, UCare and UnitedHealthcare, which administer Medicaid plans in various states, did not respond to or declined interview requests.

According to an earlier report jointly released by Independence Blue Cross and the Massachusetts Institute of Technology, insurers’ health management tools fail to consider structural racism in their machine-learning models.

Early intervention models often don’t factor in race and socioeconomic status, which could delay care and worsen inequity, according to the report. For example, medication adherence models use medical history data that reflect disparities in diagnosis, treatment and prescribing between Black and white patients, researchers found. The result is a tool that disproportionately identifies Black patients as being “noncompliant” when the true cause may be poor access to care.

“Health plans and other entities that develop and use medication adherence models must recognize how systemic biases in access to pharmacies and prescription drugs, prescribing patterns, and utilization in Black and brown communities affect problem formulation, algorithm development and interpretation, and intervention strategies,” the Independence Blue Cross-MIT report says.

Increasing the amount and types of patient data for insurers could improve these tools, the report concludes. Insurers are preparing to categorize claims data by race and ethnicity to identify inequities across groups.

Insurers are also trying to better understand the barriers their members face to health and want cooperation from the government and from community organizations. According to the survey, 90% of managed care organizations said their state Medicaid programs should improve data-sharing between foster care agencies and the criminal justice system, and another 86% want more information from community groups, for instance.

Developing partnerships with community organizations can enhance access to data on barriers to health, Karen Dale, chief diversity, equity, and inclusion officer at AmeriHealth Caritas, said in during an Institute for Medicaid Innovation panel discussion Friday. Insurers should use such data to target interventions, then get feedback on the results from all parties involved, she said.

“We should be doing that work,” Dale said. “It’s all about who we serve and increasing opportunities for them to be healthy.”

Regulations governing insurance companies’ algorithms and artificial intelligence tools are in their infancy. For example, the Food and Drug Administration recently announced it would review medical devices for evidence of bias and inequity. On Wednesday, an FDA advisory panel met to evaluate pulse oximeters, which may overestimate oxygen concentrations among patients with darker skin. 

[ad_2]

Source link

slot gacor slot gacor togel macau slot hoki bandar togel slot dana slot mahjong link slot link slot777 slot gampang maxwin slot hoki slot mahjong slot maxwin slot mpo slot777 slot toto slot toto situs toto toto slot situs toto situs toto situs toto situs toto slot88 toto slot slot gacor thailand slot bet receh situs toto situs toto slot toto slot situs toto situs toto situs toto situs togel macau toto slot slot demo slot pulsa slot pragmatic situs toto deposit dana 10k surga slot toto slot link situs toto situs toto slot situs toto situs toto slot777 slot gacor situs toto slot slot pulsa 10k toto togel situs toto slot situs toto slot gacor terpercaya slot dana slot gacor pay4d agen sbobet kedai168 kedai168 deposit pulsa situs toto slot pulsa situs toto slot pulsa situs toto situs toto situs toto slot dana toto slot situs toto slot pulsa toto slot situs toto slot pulsa situs toto situs toto situs toto toto slot toto slot slot toto akun pro maxwin situs toto slot gacor maxwin slot gacor maxwin situs toto slot slot depo 10k toto slot toto slot situs toto situs toto toto slot toto slot toto slot toto togel slot toto togel situs toto situs toto toto slot slot gacor slot gacor slot gacor situs toto situs toto cytotec toto slot situs toto situs toto toto slot situs toto situs toto slot gacor maxwin slot gacor maxwin link slot 10k slot gacor maxwin slot gacor slot pulsa situs slot 10k slot 10k toto slot toto slot situs toto situs toto situs toto bandar togel 4d toto slot toto slot